Trading Signals: AUTL Stock Price Prediction and Forecast (Fri. Jun. 22, 2018 - Fri. May. 13, 2022)(Autolus Therapeutics plc )
| AUTL latest price $9.9700 (0.2%) ($9.8000 - $10.5600) on Wed. Dec. 2, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.01% (three month average) | RSI | 47 | Latest Price | $9.9700(0.2%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | AUTL declines -0.1% a day on average for past five trading days. | Weekly Trend | AUTL declines -3.4% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Value stock rally for small cap. | Correlated ETFs | Broad market will support AUTL advance at 0% a week (0% probability) ARKG(12%) BLOK(12%) BNDX(12%) SKYY(12%) XBI(12%) | Factors Impacting AUTL price | AUTL will decline at least -2.005% in a week (0% probabilities). TBT(-8%) USO(-7%) VIXM(-6%) UNG(-6%) XLF(-3%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.005% (StdDev 4.01%) | Hourly BBV | -1.2 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-0.3(-103.01%) | Inflection Point | Yes | Resistance Level | $10.71 | 5 Day Moving Average | $10.13(-1.58%) | 10 Day Moving Average | $10.35(-3.67%) | 20 Day Moving Average | $10.71(-6.91%) | To recent high | -30.2% | To recent low | 3.4% | Market Cap | $521m | | | | Autolus Therapeutics Plc is a biopharmaceutical company. It engages in the development of cancer treatments. The firm's portfolio includes B Cell Malignancies, Multiple Myeloma, T Cell Lymphoma, GD2+ Tumors, and Prostate Cancer. The company was founded by Martin Pulé in February 2018 and is headquartered in London, the United Kingdom. |